An EU pharmaceutical licensed company, MGC Pharmaceuticals Ltd (ASX: MXC),(MGCLF: OTC US) is driven by the goal to make Phytomedicines available in pharmacies and to patients in need, in the most cost-effective, consistent and efficient manner possible.
With many years of real-world, technical and professional experience, MGC Pharma’s founders are all celebrated trailblazers in the Phytocannabinoid industry. MGC Pharma’s main objective is to create and supply superb Cannabinoid based pharmaceutical products for medical markets in North America, Europe, and Australasia.